Trial
NCT01573780
Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
TetraLogic Pharmaceuticals
Condition
Unspecified Adult Solid Tumor, Protocol Specific
Intervention
Smac mimetic TL32711
Why stopped
Sponsor did not have funds to continue study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-15